HCA Healthcare (HCA) Projected to Post Earnings on Friday

HCA Healthcare (NYSE:HCA) is anticipated to post its Q2 2026 results before the market opens on Friday, July 24th. Analysts expect the company to post earnings of $7.52 per share and revenue of $19.6755 billion for the quarter. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Investors may visit the the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Friday, July 24, 2026 at 10:00 AM ET.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. During the same period in the prior year, the business posted $6.45 EPS. The business’s revenue was up 4.3% on a year-over-year basis. On average, analysts expect HCA Healthcare to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

HCA Healthcare Trading Up 1.8%

Shares of NYSE HCA opened at $385.71 on Friday. The stock has a fifty day moving average price of $393.51 and a 200 day moving average price of $457.65. The company has a market cap of $85.57 billion, a P/E ratio of 13.26, a P/E/G ratio of 1.25 and a beta of 1.12. HCA Healthcare has a 12-month low of $330.00 and a 12-month high of $556.52.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were given a dividend of $0.78 per share. The ex-dividend date of this dividend was Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s payout ratio is 10.73%.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Some analysts remain constructive, with one Seeking Alpha piece arguing HCA’s recent underperformance may already reflect the biggest policy and margin concerns, and that the stock could be set up for a rebound if fundamentals stabilize.
• Neutral Sentiment: Barclays lowered its price target on HCA Healthcare from $427 to $402 and kept an equal-weight rating, signaling a more cautious near-term view even though the new target still implies modest upside from current levels. Barclays Cuts HCA Price Target
• Neutral Sentiment: Several articles noted that HCA’s stock still looks discounted relative to its long-term earnings power, but valuation arguments may be offset by growing concerns around reimbursement pressure and insurance coverage losses.
• Negative Sentiment: HCA cut its 2026 earnings outlook after reporting that federal policy changes, a worsening payer mix, and more uninsured patients could reduce profits by roughly $1 billion, raising concerns about margin compression and slower growth. HCA Cuts 2026 Earnings Forecast
• Negative Sentiment: Reports also highlighted a $400 million hit linked to policy changes and weaker earnings quality, since part of the quarterly beat was helped by a one-time Medicaid payment rather than underlying operating strength.
• Negative Sentiment: Labor and contract issues at one HCA hospital added another headline risk, though this appears less material than the company’s earnings and policy-related pressures.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Truist Financial set a $413.00 price objective on shares of HCA Healthcare in a research report on Thursday, June 4th. Wells Fargo & Company lowered their price target on shares of HCA Healthcare from $436.00 to $428.00 and set an “equal weight” rating for the company in a report on Monday. Barclays decreased their price objective on shares of HCA Healthcare from $427.00 to $402.00 and set an “equal weight” rating for the company in a research report on Thursday. JPMorgan Chase & Co. cut their price target on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 19th. Finally, Oppenheimer dropped their price target on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Fourteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $486.14.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Brighton Jones LLC bought a new stake in HCA Healthcare during the 4th quarter valued at $1,021,000. NewEdge Advisors LLC increased its holdings in shares of HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after purchasing an additional 409 shares during the period. Sivia Capital Partners LLC lifted its holdings in HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares during the period. Jump Financial LLC acquired a new position in HCA Healthcare during the 2nd quarter valued at about $2,073,000. Finally, Sei Investments Co. lifted its stake in shares of HCA Healthcare by 56.3% in the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after acquiring an additional 49,214 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.